CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a $2 fungus pill stop esophageal cancer before it starts?
Prevention Not yet recruitingThis study tests whether adding the antifungal drug itraconazole to standard heat ablation therapy can better prevent esophageal cancer in people with high-risk Barrett's esophagus. About 64 participants will receive either itraconazole or a placebo alongside their usual endoscop…
Matched conditions: CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 11, 2026 20:47 UTC
-
New study tracks physical decline during cancer treatment
Knowledge-focused Not yet recruitingThis study follows 72 adults with early-stage gastroesophageal cancer to see how their physical function changes during chemotherapy. Participants will complete simple physical tests and surveys before, during, and after treatment. The goal is to better understand which patients …
Matched conditions: CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC